
About Famy Life Sciences Private Limited
Data last updated:
Famy Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 27 October 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U40109TS2008PTC188720. Its GSTIN is 08AABCF3176G1ZP (Rajasthan). The company holds 6 GST registrations, of which 5 are active.
The company has an authorised share capital of ₹1.51 Cr and a paid-up capital of ₹1.42 Cr. It was formerly known as Famy Energy Private Limited. It is led by directors Ajay Singh Rathore and Nagaraj Goud Bodige.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 564/A/22 Road No. 92, Hyderabad Telangana 500096, Telangana, India – 500096.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.36 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net loss of ₹178.26 Cr and EBITDA of -₹178.24 Cr. Revenue has declined at a compounded annual rate (CAGR) of 70% over three years and 52% over five years.
The company has about 8 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Famy Life Sciences. As per MCA filings, the company has satisfied charges of ₹110 Cr on record. Court records list 10 cases involving the company, including 8 filed by the company and 2 filed against it. The company has 10 deals on record (7 secondary share transfers, 1 funding round, 1 convertible or debt financing), with disclosed funding of ₹179.24 Cr; the latest was in October 2023. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger and 3 smaller; the largest is Levin Formulations Private Limited with revenue of ₹2.36 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website famylifesciences.com.
Company details
CIN history
Famy Life Sciences has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U40109TS2008PTC188720, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U40109TS2008PTC188720 | Current |
| U40109GJ2008PTC109640 | Previous |
| U40109MH2008PTC187793 | Previous |
Contact details
Famy Life Sciences Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressPlot No. 564/A/22 Road No. 92, Hyderabad Telangana 500096, Telangana, India – 500096
- IndustryTrading, Wholesale, Other Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Famy Life Sciences operates one associated brand: Famy Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Drug development services are offered for ophthalmology, oncology, and dermatology. | famylifesciences.com |
Business activity
The main business activity of Famy Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Famy Life Sciences Private Limited, buy the company report.
Financials of Famy Life Sciences Private Limited
FY 2025 filings availableFamy Life Sciences Private Limited reported revenue of ₹2.36 Cr (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 9% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 52%. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹178.24 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹178.26 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Famy Life Sciences Private Limited, buy the company report.
Board of directors of Famy Life Sciences Private Limited
Famy Life Sciences has 2 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Singh Rathore Also directs: Mylan Pharmaceuticals Private Limited | Director | 10 Feb 2023 | 3 Years 9 Months | Current |
| Nagaraj Goud Bodige Also directs: Mylan Laboratories Limited | Director | 13 Mar 2025 | 1 Years 8 Months | Current |
Peer comparison
Famy Life Sciences Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Levin Formulations Private Limited | ₹2.36 Cr (FY 2025) | -13.0% | Hyderabad, Telangana, India | |||
| Wagnerhuber Pharmaceuticals Private Limited | ₹2.36 Cr (FY 2025) | -8.0% | Chandigarh, India | |||
| Zupisure Formulations Private Limited | ₹2.36 Cr (FY 2025) | 35.0% | Mumbai, Maharashtra, India | |||
| Famy Life Sciences Private Limitedthis company | ₹2.36 Cr (FY 2025) | -₹178.26 Cr | 9.0% | Hyderabad, Telangana, India | ||
| Arka Vital Science Private Limited | ₹2.36 Cr (FY 2025) | 22.0% | Chennai, Tamil Nadu, India | |||
| Quality Innovations and Pharmaceuticals India Private Limited | ₹2.36 Cr (FY 2025) | 0.0% | Thiruvananthapuram, Kerala, India | |||
| Swakam Biotech Private Limited | ₹2.35 Cr (FY 2025) | 11.0% | Chandigarh, India |
To see the full peer comparison of Famy Life Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Aug 2017 | 100120934 | Others | ₹100 Cr | Satisfied | |
| 03 Jan 2011 | 10267616 | Hdfc Bank Limited | ₹10 Cr | Satisfied |
To see the full charge records of Famy Life Sciences Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Famy Life Sciences Private Limited has 10 deals on record (7 secondary share transfers, 1 funding round, 1 convertible or debt financing), with disclosed funding of ₹179.24 Cr; the latest was in October 2023.
Deals on record (5 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2023 | Secondary share transfer | Undisclosed | Buyer: Mylan Inc, Mylan Pharmaceutical Inc Seller: Mylan Pharmaceutical Inc, an individual |
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: Mylan Pharmaceutical Inc Seller: Urmiladevi Family Trust, Ashutosh Taparia Family Trust, Aruna Taparia Family Trust |
| Mar 2023 | Rights issue | ₹26.5 Lakh | Investors: Mylan Pharmaceutical Inc |
| Feb 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Jyotiprasad Taparia HUF |
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Famy Life Sciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Famy Life Sciences Private Limited has 10 court cases on record: 8 filed by Famy Life Sciences, 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 0 | 0 |
| Supreme Court | 2 | 2 | 0 |
| NCLT | 2 | 0 | 0 |
| District courts | 1 | 0 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Appeal | Filed against the company by Deputy Commissioner of Income Tax Circle (1)(1) Mumbai | Disposed |
| Supreme Court | Appeal | Filed against the company by Deputy Commissioner of Income Tax Circle 1 (1)(1) | Disposed |
| NCLT, Ahmedabad | Court case (C.P.(CAA)) | Filed by the company | Disposed |
| High Court, MAHARASHTRA | Writ petition | Filed by the company against Deputy Commissioner of Income Tax, Circle 1( and 3 others | Disposed |
| NCLT, Ahmedabad | Court case (C.A.(CAA)) | Filed by the company | Disposed |
To see the full case history of Famy Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Famy Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Famy Life Sciences has 6 GST registrations: 5 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AABCF3176G1ZP | Rajasthan | Active | 01 Jul 2017 |
| 27AABCF3176G1ZP | Maharashtra | Active | 01 Jul 2017 |
| 27AABCF3176G2ZO | Maharashtra | Active | 05 Aug 2017 |
| 23AABCF3176G1ZX | Madhya Pradesh | Active | 29 Mar 2018 |
To see the full GST registrations and return filing status of Famy Life Sciences Private Limited, buy the company report.
Recent activity
Famy Life Sciences Private Limited has 14 board changes on record since 2018: 2 appointments and 12 cessations. The latest: Nagaraj Goud Bodige ceased to be Additional Director on 29 Sep 2025.
10 earlier events are in the company report.
Frequently asked questions
Famy Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in wholesale, within the trading industry. It was incorporated on 27 October 2008 (18+ years old) and is registered under CIN U40109TS2008PTC188720.
Famy Life Sciences has 2 current directors:
- Ajay Singh Rathore - Director
- Nagaraj Goud Bodige - Director
The latest financial statements of Famy Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Famy Life Sciences is 08AABCF3176G1ZP, registered in Rajasthan. The company has 6 GST registrations in all, of which 5 are active and 1 is cancelled or inactive. Other active GSTINs include 27AABCF3176G1ZP (Maharashtra), 27AABCF3176G2ZO (Maharashtra), 23AABCF3176G1ZX (Madhya Pradesh).
The CIN (Corporate Identification Number) of Famy Life Sciences is U40109TS2008PTC188720. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Famy Life Sciences has 10 court cases on record: 8 filed by the company and 2 filed against it. Most are in the high courts.
Famy Life Sciences was incorporated on 27 October 2008, making it 18+ years old. It is registered with the Registrar of Companies, Hyderabad.
Famy Life Sciences has 10 deals on record (7 secondary share transfers, 1 funding round, 1 convertible or debt financing), with disclosed funding of ₹179.24 Cr; the latest was in October 2023.
The peers of Famy Life Sciences by revenue are Levin Formulations Private Limited, Wagnerhuber Pharmaceuticals Private Limited, Zupisure Formulations Private Limited, Arka Vital Science Private Limited, Quality Innovations and Pharmaceuticals India Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Nagaraj Goud Bodige ceased to be Additional Director on 29 Sep 2025. Nagaraj Goud Bodige was appointed as Director on 13 Mar 2025. Ajay Singh Rathore ceased to be Additional Director on 29 Sep 2023. Famy Life Sciences has 14 board changes on record in total.
Famy Life Sciences can be reached through the website famylifesciences.com. Its registered office is in Hyderabad, Telangana, India.

